CG
ZVRA icon

Cutler Group’s Zevra Therapeutics ZVRA Stock Holding History

Cutler Group’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-200
Closed -$1K – 5182
2022
Q4 		$1K Sell
200
-1,400
-88% -$7.11K ﹤0.01% 4207
2022
Q3 		$19K Hold
1,600
– – ﹤0.01% 2671
2022
Q2 		$22K Sell
1,600
-200
-11% -$912 ﹤0.01% 2609
2022
Q1 		$21K Sell
1,800
-400
-18% -$2.54K ﹤0.01% 3042
2021
Q4 		$20K Sell
2,200
-400
-15% -$3.57K ﹤0.01% 3139
2021
Q3 		$20K Sell
2,600
-400
-13% -$4.03K ﹤0.01% 3359
2021
Q2 		$20K Sell
3,000
-7,900
-72% -$84.9K ﹤0.01% 3313
2021
Q1 		$13K Buy
+10,900
New +$95.2K ﹤0.01% 3600

Other funds holding ZVRA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
LCM
Laurion Capital Management New York $1.07B AUM 75.73% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $408M AUM 318.81% 1-Year Est. Return
RPCONE
Retirement Planning Company of New England Warwick, Rhode Island $246M AUM 27.83% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
Jane Street
Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return
MAM
Mystic Asset Management Warwick, Rhode Island $431M AUM 25.35% 1-Year Est. Return